Cytosorbents Overview
Cytosorbents Discounted Cash Flow
DCF Analysis for CTSO.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.35
Current Fair Value
$2.35
↑ 444.7% Upside
Undervalued by 444.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison